Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Aherne

Showing results (111-120 of 139) with videos related to

Pageof 14
Sort By:
British Journal of Pharmacology|June 1, 1975
Proceedings: The measurement of serum morphine levels by radioimmunoassay following oral administration of diamorphine or morphineG W Aherne, V Marks, B A Morris, et al.
Analytical Biochemistry|October 25, 2001
High-throughput screening for identification of small molecule inhibitors of histone acetyltransferases using scintillating microplates (FlashPlate)F Turlais, A Hardcastle, M Rowlands, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1984
Delayed-release bleomycin. Comparative pharmacology of bleomycin oil suspension and bleomycin in salineM L Slevin, V J Harvey, G W Aherne, et al.
British Journal of Clinical Pharmacology|October 1, 1981
The pharmacokinetics of subcutaneous cytosine arabinoside in patients with acute myelogenous leukaemiaM L Slevin, E M Piall, G W Aherne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 15, 2006
A prospective, blinded analysis of thymidylate synthase and p53 expression as prognostic markers in the adjuvant treatment of colorectal cancerS Popat, Z Chen, D Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2001
Pharmacokinetic/pharmacodynamic study of ZD9331, a nonpolyglutamatable inhibitor of thymidylate synthase, in a murine model following two curative administration schedulesG W Aherne, A Hardcastle, E Ward, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1996
Preclinical pharmacology of CB30900, a novel dipeptide inhibitor of thymidylate synthase, in miceM I Walton, W Gibson, G W Aherne, et al.
Thrombosis Research|February 15, 1982
Effects of the non-selective beta-adrenoceptor blocking agent, carteolol, on platelet function, blood coagulation and viscosityM Small, J T Douglas, G W Aherne, et al.
Investigational New Drugs|November 11, 1999
A human capecitabine excretion balance and pharmacokinetic study after administration of a single oral dose of 14C-labelled drugI R Judson, P J Beale, J M Trigo, et al.
British Journal of Cancer|May 1, 1995
Mechanisms of acquired resistance to the quinazoline thymidylate synthase inhibitor ZD1694 (Tomudex) in one mouse and three human cell linesA L Jackman, L R Kelland, R Kimbell, et al.
Pageof 14

Showing results (111-120 of 139) with videos related to

Sort By:
Pageof 14
British Journal of Pharmacology|June 1, 1975
Proceedings: The measurement of serum morphine levels by radioimmunoassay following oral administration of diamorphine or morphineG W Aherne, V Marks, B A Morris, et al.
Analytical Biochemistry|October 25, 2001
High-throughput screening for identification of small molecule inhibitors of histone acetyltransferases using scintillating microplates (FlashPlate)F Turlais, A Hardcastle, M Rowlands, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1984
Delayed-release bleomycin. Comparative pharmacology of bleomycin oil suspension and bleomycin in salineM L Slevin, V J Harvey, G W Aherne, et al.
British Journal of Clinical Pharmacology|October 1, 1981
The pharmacokinetics of subcutaneous cytosine arabinoside in patients with acute myelogenous leukaemiaM L Slevin, E M Piall, G W Aherne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 15, 2006
A prospective, blinded analysis of thymidylate synthase and p53 expression as prognostic markers in the adjuvant treatment of colorectal cancerS Popat, Z Chen, D Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2001
Pharmacokinetic/pharmacodynamic study of ZD9331, a nonpolyglutamatable inhibitor of thymidylate synthase, in a murine model following two curative administration schedulesG W Aherne, A Hardcastle, E Ward, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1996
Preclinical pharmacology of CB30900, a novel dipeptide inhibitor of thymidylate synthase, in miceM I Walton, W Gibson, G W Aherne, et al.
Thrombosis Research|February 15, 1982
Effects of the non-selective beta-adrenoceptor blocking agent, carteolol, on platelet function, blood coagulation and viscosityM Small, J T Douglas, G W Aherne, et al.
Investigational New Drugs|November 11, 1999
A human capecitabine excretion balance and pharmacokinetic study after administration of a single oral dose of 14C-labelled drugI R Judson, P J Beale, J M Trigo, et al.
British Journal of Cancer|May 1, 1995
Mechanisms of acquired resistance to the quinazoline thymidylate synthase inhibitor ZD1694 (Tomudex) in one mouse and three human cell linesA L Jackman, L R Kelland, R Kimbell, et al.
Pageof 14